Neal D. Shore, MD, FACS of Carolina Urologic Research Center gives his take on which metastatic castration-resistant prostate cancer patients should be treated with chemotherapy at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Who are the right metastatic castration-resistant prostate cancer patients that should be treated with chemotherapy
